2005 Article Archive CD from the International Journal of Pharmaceutical Compounding

Sign On

Volume 9, 2005 CD
Six back issues from 2005 on one convenient CD.

Permanent storage and easy retrieval of IJPC articles and formulations.

Print journal articles in color from the PDF file for your marketing needs.
Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.

Only $95 per CD

This CD contains the following articles listed by volume, issue and page number:


Issues Included
Volume/Issue	Date	Title
Vol. 9 No. 1	January/February 2005	Sterile Preparations
Vol. 9 No. 2	March/April 2005	Health and Wellness
Vol. 9 No. 3	May/June 2005	Veterinary Compounding
Vol. 9 No. 4	July/August 2005	Human Hormone Replacement Therapy
Vol. 9 No. 5	September/October 2005	Pain Management
Vol. 9 No. 6	November/December 2005	Pediatrics

Volume 9, 2005 CD ARTICLES

Title (Click for Details)	Vol/Issue	Page

Volume 9, 2005 CD ARTICLES
PreScription: CompoundingToday.com and Sources of Compounding Chemicals	Vol. 9 No. 1	2
Book Review: The Medical & Surgical Practice of NaProTECHNOLOGY	Vol. 9 No. 1	5
Literature Reviews	Vol. 9 No. 1	5
USP Chapter <797>: Practical Solutions for Microbiology, Sterility, and Pyrogen Testing	Vol. 9 No. 1	11
Using ACDs in the Practice of Pharmacy	Vol. 9 No. 1	15
USP Chapter <797> and Preparing for a JCAHO Survey	Vol. 9 No. 1	23
Questions and Answers: USP Chapter <797> and JCAHO Compliance	Vol. 9 No. 1	29
A Dialogue Concerning Contamination Control Systems: Where Does the Isolator Fit In?	Vol. 9 No. 1	33
The Marketing Equation Your Ad Man Doesn't Want You to Know: How to Double Your Bottom Line without Spending an Extra Dime	Vol. 9 No. 1	37
Defining Success	Vol. 9 No. 1	42
The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the "Negative List")	Vol. 9 No. 1	44
Quality-Control Analytical Methods: Microbial Testing Aspects of USP <797> for Compounded Sterile Preparations	Vol. 9 No. 1	47
Wish You Were Here: Pharmacy Museum, Weimar, Texas	Vol. 9 No. 1	50
Barrier Isolators, Isolators, and Glove Boxes--What's the Difference?	Vol. 9 No. 1	53
Calculations	Vol. 9 No. 1	57
Basics of Compounding with Acids	Vol. 9 No. 1	58
Standard Operating Procedure: Compounding with Concentrated Acids	Vol. 9 No. 1	61
Amitriptyline Hydrochloride 10-mg/mL Injection	Vol. 9 No. 1	62
Fentanyl 15-mg/mL Injection, Preservative Free	Vol. 9 No. 1	63
Gabapentin 2-mg/mL Injection, Preservative Free	Vol. 9 No. 1	64
Guaifenesin 50-mg/mL Injection	Vol. 9 No. 1	65
Lidocaine Hydrochloride-2%, Ketolorac Tromethamine-3%, and Clonidine Hydrochloride-0.1% Injection	Vol. 9 No. 1	66
Naltrexone Hydrochloride 1.4-mg/mL Injection, Preservative Free	Vol. 9 No. 1	67
Naproxen Sodium 100-mg/mL Injection	Vol. 9 No. 1	68
Phenol 8% Injection	Vol. 9 No. 1	69
Tolazoline Hydrochloride 25-mg/mL Injection	Vol. 9 No. 1	70
Tramadol Hydrochloride 50-mg/mL Injection, Preservative Free	Vol. 9 No. 1	71
Chemical Stability of Metoclopramide Hydrochloride Injection Diluted with 0.9% Sodium Chloride Injection in Polypropylene Syringes at Room Temperature	Vol. 9 No. 1	72
Physical characteristics of selected over-the-counter medications	Vol. 9 No. 1	75
Stability of an Extemporaneously Compounded Propylthiouracil Suspension	Vol. 9 No. 1	82
Scientific and Professional Reviewers for 2004	Vol. 9 No. 1	87
PostScription: Pharmacy, Pharmacists, and Pharmacy Practice	Vol. 9 No. 1	88
Prescription: Too Much Information?	Vol. 9 No. 2	90
Book Review: Bacteria for Breakfast: Probiotics for Good Health	Vol. 9 No. 2	93
Book Review: Miracle Cure: How to Solve America's Health Care Crisis and Why Canada Isn't the Answer	Vol. 9 No. 2	93
Literature Reviews	Vol. 9 No. 2	94
N-acetylcysteine Used to Decrease the Incidence of Contrast-Induced Nephropathy Following Radiographic Procedures: A Literature Review	Vol. 9 No. 2	99
Treatment of Mercury Intoxication With Dimercaptopropanesulfonate	Vol. 9 No. 2	105
What a Pharmacist Needs to Know about Bariatric Surgery: Compounding Opportunities	Vol. 9 No. 2	111
Combating Cardiovascular Disease With Compounded Medications. Part 1: Combination Cardiac Medicines to Control Blood Pressure	Vol. 9 No. 2	117
Use of Domperidone as a Prokinetic and Antiemetic	Vol. 9 No. 2	120
Proposed Revisions to USP Chapter <797> Pharmaceutical Compounding--Sterile Preparations	Vol. 9 No. 2	127
Communication Makes It or Breaks It	Vol. 9 No. 2	133
Quality-Control Analytical Methods: Chemical Testing Aspects of USP <797> for Compounded Sterile Preparations	Vol. 9 No. 2	136
Basics of Compounding for Hair Care--Part I: Medicated Shampoos	Vol. 9 No. 2	140
Standard Operating Procedure: SOP Master Book--Maintenance	Vol. 9 No. 2	145
Calculations	Vol. 9 No. 2	146
Aspirin 30-mg/mL Desensitization Oral Liquid, Nonaqueous	Vol. 9 No. 2	147
Capsaicin 0.2-mg Troches	Vol. 9 No. 2	148
Clobetasol Topical Spray	Vol. 9 No. 2	149
Clobetasol and Dyclonine Oral Paste	Vol. 9 No. 2	150
Homatropine 3-mg Rapid Dissolving Tablets	Vol. 9 No. 2	151
Isosorbide Dinitrate 0.1% Topical Spray	Vol. 9 No. 2	152
Sildenafil 1% Vaginal Cream or Gel	Vol. 9 No. 2	153
Sildenafil Vaginal Suppository	Vol. 9 No. 2	154
Silver Sulfadiazine 1% and Fluriprofen 2% Cream	Vol. 9 No. 2	155
Thiabendazole 15% Cream	Vol. 9 No. 2	156
In Vitro Evaluation of Extemporaneously Compounded Slow-Release Capsules Containing Morphine Sulfate or Oxycodone Hydrochloride	Vol. 9 No. 2	157
Chemical Stability of Isoniazid in an Oral Liquid Dosage Form	Vol. 9 No. 2	165
PostScription: Experts Everywhere	Vol. 9 No. 2	167
PreScription: Working Together: Lessons from a Rope	Vol. 9 No. 3	170
Book Reviews: Veterinary Drug Handbook: Client Information Edition	Vol. 9 No. 3	173
Book Reviews: When Change Is Your Company's Middle Name: The Professional's Guide to Understanding the Human Side of Business Transformation	Vol. 9 No. 3	173
Literature Reviews	Vol. 9 No. 3	174
Update on Transdermals for Animal Patients	Vol. 9 No. 3	178
Compounding for Behavior Problems in Animals	Vol. 9 No. 3	185
Compounding Antiangiogenic Cancer Therapy for Animals	Vol. 9 No. 3	195
Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs	Vol. 9 No. 3	201
Quality-Control Analytical Methods: Determination of Tapped Bulk Volume for Compounded Prescriptions	Vol. 9 No. 3	207
Survey of State Veterinary Compounding Laws and Regulations	Vol. 9 No. 3	209
What Customers Want	Vol. 9 No. 3	213
Basics of Compounding for Hair Care -- Part 2: Medicated Conditions	Vol. 9 No. 3	215
Pharmacy History: Pharmacy Knots	Vol. 9 No. 3	220
Standard Operating Procedure: Exhaust System Airflow Monitoring (Individual Capsule Stations)	Vol. 9 No. 3	222
Calculations	Vol. 9 No. 3	224
Calcitriol 100 ng/mL Oral Liquid, Veterinary	Vol. 9 No. 3	225
Dexamethasone Oral Powder 10-mg Units, Veterinary	Vol. 9 No. 3	226
Dipyrone 500-mg/mL Injection, Veterinary	Vol. 9 No. 3	227
Meloxicam 0.2 mg/mL Oral Liquid, Veterinary	Vol. 9 No. 3	228
Methimazole 10-mg/mL Oral Liquid, Veterinary	Vol. 9 No. 3	229
Metronidazole 1% and Silver Sulfadiazine 1% Cream, Veterinary	Vol. 9 No. 3	230
Pergolide 500-mcg Capsules, Veterinary	Vol. 9 No. 3	231
Pergolide 0.2-mg/mL Oral Liquid, Veterinary	Vol. 9 No. 3	232
Phenoxybenzamine Hydrochloride 5-mg Capsules, Veterinary	Vol. 9 No. 3	233
Piroxicam 2-mg/mL Oral Liquid, Veterinary	Vol. 9 No. 3	234
Physical and Chemical Stability of Palonosetron Hydrochloride with Lorazepam and Midazolam Hydrochloride during Simulated Y-Site Administration	Vol. 9 No. 3	235
Physical and Chemical Stability of Palonosetron Hydrochloride with Topotecan Hydrochloride and Irinotecan Hydrochloride during Simulated Y-Site Administration	Vol. 9 No. 3	238
Bioavailability of Promethazine in a Topical Pluronic Lecithin Organogel: A Pilot Study	Vol. 9 No. 3	242
PostScription: AVMA's Position on Compounding for Animals	Vol. 9 No. 3	247
Prescription: Support Your Local College of Pharmacy	Vol. 9 No. 4	250
Book Reviews: Awakening Athena: Resilience, Restoration, and Rejuvenation for Women	Vol. 9 No. 4	252
Book Reviews: Perfect Balance	Vol. 9 No. 4	253
Literature Reviews	Vol. 9 No. 4	254
Testosterone Replacement Therapy for Female Androgen Insufficiency Syndrome	Vol. 9 No. 4	259
Guidelines for Consulting with Patients about Bioidentical Hormone Replacement Therapy	Vol. 9 No. 4	266
Hypothyroidism: Optimizing Therapy with Slow-Release Compounded Thyroid Replacement	Vol. 9 No. 4	268
Compounding for Endocrine Disorders in Adult Patients	Vol. 9 No. 4	275
Natural Progesterone Handout	Vol. 9 No. 4	281
Considerations for Choosing a Primary Engineering Control for Compounding Sterile Products	Vol. 9 No. 4	284
Local Ventilation for Safe Containment in the Pharmaceutical Industry	Vol. 9 No. 4	293
Quality-Control Analytical Methods: Glossary of Quality Control/Quality Assurance Terms in Pharmaceutical Compounding	Vol. 9 No. 4	300
Basics of Pharmacogenomics for the Compounding Pharmacist	Vol. 9 No. 4	303
Calculations	Vol. 9 No. 4	307
Standard Operating Procedure: Employee Personnel Records	Vol. 9 No. 4	309
BMS Mouthwash	Vol. 9 No. 4	310
Bonain's Solution	Vol. 9 No. 4	311
Brompton's Mixture	Vol. 9 No. 4	312
Bunnel's Solutions	Vol. 9 No. 4	313
Burow's Solution	Vol. 9 No. 4	314
Joulie's Solution	Vol. 9 No. 4	315
Shohl's Solution, Modified (Albright's Solution)	Vol. 9 No. 4	316
Suby-Albright Solution "G" Irrigation	Vol. 9 No. 4	317
Suby-Albright Solution "M" Irrigation	Vol. 9 No. 4	318
Whitehead's Varnish	Vol. 9 No. 4	319
Physical and Chemical Stability of Palonosetron Hydrochloride with Fluorouracil and with Gemcitabine Hydrochloride during Simulated Y-site Administration	Vol. 9 No. 4	320
Stability of Nebulizer Admixtures	Vol. 9 No. 4	323
PostScription: Women in Balance: A Cause Worth Advancing	Vol. 9 No. 4	327
Prescription: Pharmacy Compounding Worldwide	Vol. 9 No. 5	330
Book Reviews: Lawsuit Lottery: The Hijacking of Justice in America	Vol. 9 No. 5	332
Literature Reviews	Vol. 9 No. 5	333
Dextromethorphan, an NMDA receptor antagonist, as a Treatment for Pain	Vol. 9 No. 5	339
Prescription for Relief: One Woman's Experience with Intractable Nonmalignant Pain	Vol. 9 No. 5	349
A Patient's Guide to Transdermal Treatment of Pain	Vol. 9 No. 5	354
Formulating for the Gluten-sensitive Individual	Vol. 9 No. 5	357
Basics of Compounding: Using Chemical Conversion Factors	Vol. 9 No. 5	361
Compounding: A Well-established Practice in 1938	Vol. 9 No. 5	364
Technology Update: An Overview of PDA-based Software Applications for Practicing Pharmacists	Vol. 9 No. 5	369
Back to the Basics of Business	Vol. 9 No. 5	380
Standard Operating Procedure: Denver Instrument Company M-120 Analytical Balance--Calibration, Cleaning, and Use	Vol. 9 No. 5	382
Calculations	Vol. 9 No. 5	384
Acetaminophen 400-mg, Aspirin 250-mg, Codeine Phosphate 30-mg with Antacids Capsules	Vol. 9 No. 5	386
Acetaminophen 325-mg, Codeine Phosphate 32.5-mg, and Phenyltoloxamine Citrate 30-mg Capsules	Vol. 9 No. 5	387
Aspirin 380-mg, Caffeine 30-mg, and Codeine Phosphate 30-mg Capsules	Vol. 9 No. 5	388
Aspirin 325-mg, Codeine Phosphate 30-mg, Aluminum Glycinate 48.6-mg, and Magnesium Carbonate 97.2-mg Capsules	Vol. 9 No. 5	389
Meperidine Hydrochloride 50-mg and Atropine Sulfate 0.4-mg/mL Injection	Vol. 9 No. 5	390
Meperidine Hydrochloride 50-mg and Promethazine Hydrochloride 12.5-mg Capsules	Vol. 9 No. 5	391
Meperidine Hydrochloride 50-mg and Promethazine Hydrochloride 25-mg Capsules	Vol. 9 No. 5	392
Methadone Hydrochloride 0.33-mg/mL Oral Solution	Vol. 9 No. 5	393
Morphine Sulfate 16-mg and Atropine Sulfate 0.4-mg/mL Injection	Vol. 9 No. 5	394
Morphine Sulfate 5-mg/mL PCA Injection (Concentration May Vary)	Vol. 9 No. 5	395
Stability and Subjective Taste Acceptability of Four Glycopyrrolate Solutions for Oral Administration	Vol. 9 No. 5	396
Chemical Stability of Hydralazine Hydrochloride after Reconstruction in 0.9% Sodium Chloride Injection or 5% Dextrose Injection for Infusion	Vol. 9 No. 5	399
Stability of Sotalol Hydrochloride in Extemporaneously Prepared Oral Suspension Formulations	Vol. 9 No. 5	402
PostScription: Searching for Barrier Isolator Information?	Vol. 9 No. 5	407
Prescription: Pediatric Formulation Initiatives	Vol. 9 No. 6	410
Unlocking Autism: Is Compounding the Key?	Vol. 9 No. 6	413
Compounding for a Pediatric Hospital	Vol. 9 No. 6	423
Wiping Out Diaper Rash	Vol. 9 No. 6	433
Pediatric Oral Liquid Preparations	Vol. 9 No. 6	437
Marketing Your Business for Success	Vol. 9 No. 6	445
Compounding Around the World: Portugal	Vol. 9 No. 6	449
Profile: The McGuff Companies. Part 1: Compounding and Manufacturing Share Facilities and Build Corporate Success	Vol. 9 No. 6	452
Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions	Vol. 9 No. 6	456
Quality Control Analytical Methods: Quality Issues Related to Compounding with Commercial Products	Vol. 9 No. 6	462
Standard Operating Procedure: Washing Glassware and Equipment Used in Compounding Nonsterile Preparations	Vol. 9 No. 6	470
Calculations	Vol. 9 No. 6	471
Alprazolam 1-mg/mL Oral Liquid	Vol. 9 No. 6	472
Bethanechol 5-mg/mL Oral Liquid	Vol. 9 No. 6	473
Clonazepam 0.1-mg/mL Oral Liquid	Vol. 9 No. 6	474
Dolasetron 10-mg/mL Oral Liquid	Vol. 9 No. 6	475
Ganciclovir 100-mg/mL Oral Liquid	Vol. 9 No. 6	476
Isradipine 1-mg/mL Oral Liquid	Vol. 9 No. 6	477
Pyrazinamide 10-mg/mL Oral Liquid	Vol. 9 No. 6	478
Quinidine Sulfate 10-mg/mL Oral Liquid	Vol. 9 No. 6	479
Ursodiol 25-mg/mL Oral Liquid	Vol. 9 No. 6	480
Valganciclovir Hydrochloride 60-mg/mL Oral Liquid	Vol. 9 No. 6	481
Chemical Stability of Fentanyl in Polypropylene Syringes and Polyvinylchloride Bags	Vol. 9 No. 6	482
Chemical Stability of Perphenazine in Oral Liquid Dosage Forms	Vol. 9 No. 6	484
PostScription: Compounding Pharmacies and the Successful Treatment of Autism	Vol. 9 No. 6	487